Journal of Oral Science Research ›› 2017, Vol. 33 ›› Issue (5): 574-576.DOI: 10.13701/j.cnki.kqyxyj.2017.05.027

Previous Articles    

Study of Follicle Stimulating Hormone(FSH) in Postmenopausal-osteoporosis and Oral Bone Resorption Disease.

GUAN Xiao-yue, QIAN Hua, BIAN Zhuan*.   

  1. School and Hospital of Stomatology, Key Lab for Oral Biomedical Engineering of Ministry of Education, Wuhan University, Wuhan 430079, China.
  • Received:2016-04-27 Online:2017-05-20 Published:2017-05-26

Abstract: Follicle stimulating hormone (FSH) is glycoprotein hormone produced and secreted by animal anterior pituitary basophils. In recent years, studies have shown that FSH can directly regulate the bone mass and affect the postmenopausal osteoporosis. Postmenopausal osteoporosis can affect the alveolar bone mass, in addition, it can influence oral bone resorption disease. In this review, we will provide a brief introduction to the FSH and its affecion in postmenopausal osteoporosis and oral bone resorption disease.

CLC Number: